It doesn't really matter what word you use, because they are now trying again but using live samples.Science is just like that, you have to set upper and lower limits and then test within. Company thought using stored samples may have done the job but I guess the inconsistency proved otherwise. But it doesn't mean the whole saliva concept is invalid.
Even if saliva sampling was a success, they will still need to figure out how to best extract samples and therefore can update the instructions, so maybe that's why the live trial will be best. Extract samples from the same patient using different methods then compare which way gives the most accurate reading. IMO that's the information they couldn't have gotten from stored samples.
Nonetheless, if the company didn't they live trials will give us a better chance, they would have just pulled the plug like Sona did. And with the additional trials of different sampling methods, they will give us a less invasive test.
- Forums
- ASX - By Stock
- ADO
- Ann: AnteoTech Signs Australian Distribution Agreement for EuGeni
Ann: AnteoTech Signs Australian Distribution Agreement for EuGeni, page-116
-
- There are more pages in this discussion • 86 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADO (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.2¢ |
Change
0.001(4.76%) |
Mkt cap ! $51.83M |
Open | High | Low | Value | Volume |
2.1¢ | 2.2¢ | 2.1¢ | $12.91K | 587.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 371473 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 289608 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 371473 | 0.021 |
13 | 2204550 | 0.020 |
8 | 2890767 | 0.019 |
10 | 1652665 | 0.018 |
3 | 94160 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 289608 | 2 |
0.023 | 864053 | 6 |
0.024 | 1306228 | 3 |
0.025 | 214144 | 4 |
0.027 | 680612 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online